Peter Spengler News Today

In a research note published by Peter Spengler, DZ Bank gives a Neutral rating to the stock.

DZ Banks analyst Peter Spengler upgrades the rating on the company from Sell to Neutral.

In a research note, DZ Bank analyst Peter Spengler has maintained his recommendation on the stock with a Neutral rating.

In his latest research note, analyst Peter Spengler confirms his positive recommendation. The broker DZ Bank is keeping its Buy rating.

In a research note, DZ Bank analyst Peter Spengler has maintained his recommendation on the stock with a Neutral rating.

Bad news from two divisions sent Bayer shares on a steep slide on Monday. The agrochemical and pharmaceutical company not only received a new low blow in the glyphosate dispute in the USA. Even more...

In his latest research note, analyst Peter Spengler confirms his recommendation. The broker DZ Bank is keeping its Neutral rating.

BASF s recent strong cash inflow convinced investors on Tuesday and gave the shares significant price gains. The otherwise still rather dismal business performance hardly came as a surprise; rather,...

In his latest research note, analyst Peter Spengler confirms his positive recommendation. The broker DZ Bank is keeping its Buy rating.

In his latest research note, analyst Peter Spengler confirms his positive recommendation. The broker DZ Bank is keeping its Buy rating.